Biological Characterization and DIVA Potential of Three Rough Brucella melitensis Vaccine Strains
Vaccines · 13.08.2025 · 13 (8) · 857
DOI: 10.3390/vaccines13080857 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 13.08.2025. Verfasst von Jinyue Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hebei Key Laboratory of Preventive Veterinary Medicine, College of Animal Science and Technology, Hebei Normal University of Science and Technology, …. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Hebei Agriculture Research System.
Abstract (Originalsprache)
Background
Brucellosis is a zoonotic bacterial disease primarily controlled through quarantine, culling, and vaccination. Live attenuated vaccines remain the most effective countermeasure, yet their application is limited by residual virulence and diagnostic interference. This study developed three rough-type attenuated Brucella melitensis mutants (G7, G8, G16) and evaluated their potential as DIVA (Differentiating Infected from Vaccinated Animals) vaccine candidates.
Methods
Rough phenotypes were characterized through heat agglutination, acridine orange staining, and immunoblotting. Macrophage cytotoxicity was assessed via LDH release assays, while RT-qPCR analyzed macrophage activation capacity. Mouse infection and immunization-challenge experiments, complemented by histopathology, evaluated residual virulence and protective immunity. Antibody profiles were determined by ELISA, and DIVA capability was verified using LPS-coated ELISA.
Results
G7 and G8 exhibited complete rough phenotypes, whereas G16 retained partial O-antigen (semi-rough). All rough mutants induced macrophage cytotoxicity and activation. The strains showed attenuated virulence with no viable bacteria recovered from spleens at 4 weeks post-inoculation. Histopathology revealed no liver lesions at 6 weeks post-inoculation. Immunized mice predominantly produced IgG2a-dominated Th1-type responses. The immune protection levels of G7 and G16 matched the reference vaccine M5–90Δ26, while G8 showed slightly lower efficacy. LPS-ELISA effectively differentiated vaccinated from infected animals via concurrent IgM/IgG detection.
Conclusions
This study demonstrates that the rough-type B. melitensis mutants G7 and G16 serve as promising DIVA vaccine candidates, offering strong protection with low residual virulence while enabling serological differentiation between vaccinated and infected animals, highlighting their potential as effective vaccines for brucellosis control.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hebei Key Laboratory of Preventive Veterinary Medicine, College of Animal Science and Technology, Hebei Normal University of Science and Technology, Qinhuangdao 066600, China.
- Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai 200241, China.
ORCID-Profile: Yanqing Bao, Tonglei Wu, Mingxing Tian
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Hebei Agriculture Research System
- Agricultural Science and Technology Innovation Program
Zitieren
APA
Liu, J., Yin, Y., Yang, X., Li, M., Qu, J., Wang, S., Bao, Y., Qi, J., Wu, T., & Tian, M. (2025). Biological Characterization and DIVA Potential of Three Rough Brucella melitensis Vaccine Strains. Vaccines, 13(8), 857. https://doi.org/10.3390/vaccines13080857
Vancouver
Liu J, Yin Y, Yang X, Li M, Qu J, Wang S, et al. Biological Characterization and DIVA Potential of Three Rough Brucella melitensis Vaccine Strains. Vaccines. 2025;13(8):857. doi:10.3390/vaccines13080857
BibTeX
@article{Liu2025,
author = {Liu, Jinyue and Yin, Yi and Yang, Xinmei and Li, Mengsi and Qu, Jing and Wang, Shaohui and Bao, Yanqing and Qi, Jingjing and Wu, Tonglei and Tian, Mingxing},
title = {Biological Characterization and DIVA Potential of Three Rough Brucella melitensis Vaccine Strains},
journal = {Vaccines},
year = {2025},
volume = {13},
number = {8},
pages = {857},
doi = {10.3390/vaccines13080857}
}
EUVIMED